Loading
Please wait while we load your information from QuoteMedia.
Loading
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
Please wait while we load your information from QuoteMedia.
As of January 3, 2025 • 10:31 PM ET
As of January 3, 2025 • 10:31 PM ET
Date/Time | Source | News Release |
---|---|---|
11/13/2024 07:49 PM EST | SeekingAlpha | BioCardia, Inc. (BCDA) Q3 2024 Earnings Call Transcript |
11/13/2024 04:26 PM EST | SeekingAlpha | BioCardia GAAP EPS of -$0.61 beats by $0.58 |
11/13/2024 06:00 AM EST | US Earnings Reports | Expected US Company Earnings on Wednesday, November 13th, 2024 |
11/13/2024 04:36 AM EST | US Earnings Reports | Expected earnings - BioCardia Inc. |
11/12/2024 09:45 AM EST | Zacks | Femasys Inc. (FEMY) Reports Q3 Loss, Tops Revenue Estimates |
11/06/2024 09:15 AM EST | Zacks | Urogen Pharma (URGN) Reports Q3 Loss, Tops Revenue Estimates |
11/04/2024 08:15 AM EST | Zacks | Precision BioSciences (DTIL) Reports Q3 Loss, Misses Revenue Estimates |
10/31/2024 05:15 PM EDT | Zacks | ChromaDex (CDXC) Beats Q3 Earnings and Revenue Estimates |
10/30/2024 05:25 PM EDT | Zacks | MiMedx (MDXG) Q3 Earnings and Revenues Surpass Estimates |
09/18/2024 08:35 AM EDT | SeekingAlpha | BioCardia regains compliance with Nasdaq Capital Market |
Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.